Profund Advisors’s Immunomedics Inc IMMU Stock Holding History

Profund Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-38,237	Closed	-$3.25M	–	1220
2020 Q3	$3.25M	Sell	38,237 -7,818	-17%	-$395K	0.17%	106
2020 Q2	$1.63M	Buy	46,055 +8,628	+23%	+$252K	0.09%	193
2020 Q1	$505K	Sell	37,427 -15,477	-29%	-$260K	0.04%	360
2019 Q4	$1.12M	Buy	52,904 +9,480	+22%	+$167K	0.05%	323
2019 Q3	$576K	Sell	43,424 -2,581	-6%	-$37.9K	0.03%	534
2019 Q2	$638K	Sell	46,005 -3,983	-8%	-$59.9K	0.03%	528
2019 Q1	$960K	Buy	49,988 +341	+0.7%	+$5.5K	0.05%	355
2018 Q4	$708K	Sell	49,647 -9,575	-16%	-$190K	0.04%	360
2018 Q3	$1.23M	Buy	+59,222	New	+$1.4M	0.05%	324

Profund Advisors's IMMU Position: Q4 2020 in Review

Profund Advisors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 38,237 shares — an estimated $3.25M sold.

Profund Advisors first reported a position in IMMU in Q3 2018 and held it in 9 quarters. The position peaked at $3.25M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Profund Advisors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Profund Advisors sold 38,237 Immunomedics Inc shares in Q4 2020, an estimated $3.25M.
Profund Advisors first reported a position in Immunomedics Inc in Q3 2018 and held it in 9 quarters.
Profund Advisors's Immunomedics Inc position peaked at $3.25M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Profund Advisors's 13F filing for Q4 2020, filed 9 Feb 2021.